OpenAlex
PricingAboutJobs
Log inGet started
Work

Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase

HTML

Year: 2008
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm8004527
Authors: Dirk A. Heerding, Nelson Rhodes, Jack D. Leber, Tammy J. Clark, Richard M. Keenan, Louis V. Lafrance, Mei Li, Igor G. Safonov, Dennis T. Takata, Joseph W. Venslavsky, Dennis S. Yamashita, Anthony E. Choudhry, Robert A. Copeland, Zhihong Lai, Michael D. Schaber, Peter J. Tummino, Susan L. Strum, Edgar R. Wood, Derek R. Duckett, Derek Eberwein, Victoria B. Knick, Timothy J. Lansing, Randy T. McConnell, ShuYun Zhang, Elisabeth A. Minthorn, Nestor O. Concha, Gregory L. Warren, Rakesh Kumar
Institution: GlaxoSmithKline (United States)
Language: English

Topic: PI3K/AKT/mTOR signaling in cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: GSK690693, AKT inhibitors, pan-AKT inhibitor, ATP-competitive kinase inhibitors, GSK3β phosphorylation, anti-apoptotic signaling, imidazo[4,5-c]pyridine, oxadiazole, structure-activity optimization, tumor growth inhibition
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2164090974
FWCI: 3.373
Cites: 31
Cited by: 182
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms